OpenAI has agreed to acquire Astral, a startup behind widely used Python development tools, in a deal designed to sharpen its ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT owner looks to strengthen its portfolio against rival Anthropic and gain more share in the ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...